Thierry ROUMEGUERE, MD, PhD
Urologic cancers include cancers of the prostate, bladder, kidney and male genitals.
Prostate cancer is the most common cancer in humans, it affects more than 1 in 6 men over 50y and it is the 3rd cause of human cancer mortality, so the majority of patients do not die.
Bladder cancer and urinary tract is the 4th most common cancer in humans, the 11th in women but in the latter the frequency tends to increase due to its association with smoking. It has a very high recidivism rate.
Kidney cancer often affects relatively young men and women. There is increasing use of conservative surgery for small lesions.
Testicular cancers mainly affect young men between the ages of 20 and 50 and benefit from early diagnosis so that they be curable.
The department is investigating better ways to diagnose and treat urologic cancers by developing targeted therapies that are better tolerated by the patients. The genetic analysis of tumors and the search for specific markers is of high interest to predict how the cancer will respond to chemotherapy and helps to guide treatments.